Stock screener

MPLT

Conviction 0HealthcareScan · Thu, Sep 24, 2026

MapLight Therapeutics, Inc. (MPLT) closed at $10.81 (+0.37%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, -72.8% from its 52-week high, -35.5% year to date. Sector: Healthcare · Biotechnology.

MPLT$10.81+0.37%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
4
12
14
Vol MA14 585.27K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
MapLight Therapeutics, Inc.Biotechnologywww.maplightrx.com ↗
Price10.81
Change+0.37%
Gap-1.67%
Rel volume0.92×
Avg volume606.65K
Avg $ vol7.44M
SMA 2012.40
SMA 5015.70
SMA 20021.80
Price vs 50-31.15%
Price vs 200-50.42%
MA stackbearish
50/200 cross—
Supertrenddown · 13.18
RSI (14)31
MACD hist0.08
MACD cross—
Stoch %K / %D17 / 14
ADX (14)33
+DI / −DI12 / 30
RSI divergenceBullish
MACD divergenceBullish
ATR %9.56%
ADR %6.84%
52w high39.80
52w low9.91
From 52w high-72.84%
Above 52w low+9.14%
New 52w highNo
SqueezeOff
Bollinger width36.27%
%B0.15
Donchian pos16.63%
Donchian high14.22
Donchian low10.13
AVWAP (52w high)15.59
vs AVWAP high-30.66%
AVWAP (52w low)12.49
vs AVWAP low-13.46%
OBV trendDown
Chaikin MF (20)-0.07
Today vs 20d0.92×
Avg vol (14d)585.27K
Avg vol (20d)606.65K
Avg $ vol (20d)7.44M
Market cap458.74M
RS Rating—
RS 3m (vs SPY)-70.67%
RS 6m (vs SPY)-57.23%
RS line new highNo
Trend template—
Technical rank9.7
1 week-4.51%
1 month-13.80%
3 months-66.18%
6 months-40.41%
1 year—
YTD-35.54%
P/E-2.85
P/B1.32
P/S—
P/FCF-3.31
EPS-18.56
Div yield—
ROE-46.27%
ROA-43.75%
Debt/Eq—
Current16.52
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-107.72%
Price target28.00
Target upside159.02%
Analyst ratingBuy
Institutional43.79%
Ent. value387.1M
Revenue—
Net income-60.19M
Gross profit—
Free cash flow-138.61M
IndustryBiotechnology
ExchangeNasdaq
Shares out42.62M
Employees133
ListedMon, Oct 27, 2025
Free float18.66M
Float %41.1%
Short interest3.43M
Days to cover5.7d
Short volume62.2%
Squeeze score77 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.32 vs −$1.40
Last surprise+5.7% beat
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank9.7 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance13.98
Support10.51
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in MPLT

All disclosures →
No recent disclosed trades by Congress in MPLT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MPLT

InsiderSideShares
Foff Erin Pennock
Chief Medical Officer · Employee Stock Option (right to buy) · 2026-08-17
Grant54.24K
GILLIS JONATHAN
CAO and Interim CFO · Voting Common Stock · 2026-08-17
Grant6.02K
Foff Erin Pennock
Chief Medical Officer · Voting Common Stock · 2026-08-17
Grant13.36K
GILLIS JONATHAN
CAO and Interim CFO · Voting Common Stock · 2026-08-17
Grant2.22K
GILLIS JONATHAN
CAO and Interim CFO · Employee Stock Option (right to buy) · 2026-08-17
Grant24.45K
GILLIS JONATHAN
CAO and Interim CFO · Employee Stock Option (Right to Buy) · 2026-08-17
Grant2.81K
Hanson Kristopher
General Counsel · Voting Common Stock · 2026-08-17
Grant7.73K
Hanson Kristopher
General Counsel · Employee Stock Option (right to buy) · 2026-08-17
Grant31.39K
Kreitzer Anatol
Chief Discovery Officer · Voting Common Stock · 2026-08-17
Grant6.02K
Kreitzer Anatol
Chief Discovery Officer · Employee Stock Option (right to buy) · 2026-08-17
Grant24.45K

SEC filings

EDGAR filings in MPLT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.